FDC has received an Establishment Inspection Report for its manufacturing facility located at MIDC Industrial Area, Waluj, Aurangabad, Maharashtra. Earlier, the USFDA had inspected the unit from August 10, 2018 to August 16, 2018. The company was issued Form 483 by the US FDA containing eight observations. The facility is considered to be acceptable with regard to current Good Manufacturing Practices (GMPs) and the inspection stands closed, FDC informed the exchanges on Wednesday. Shares of FDC ended flat at ₹201.90 on the BSE.
FDC receives EIR from USFDA for Waluj plant
Published on
October 31, 2018 14:02
Tags